PortfoliosLab logoPortfoliosLab logo
PBE vs. JEPI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PBE vs. JEPI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and JPMorgan Equity Premium Income ETF (JEPI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PBE achieves a 3.32% return, which is significantly higher than JEPI's 1.89% return.


PBE

1D
0.81%
1M
4.85%
YTD
3.32%
6M
5.17%
1Y
34.13%
3Y*
10.91%
5Y*
2.31%
10Y*
8.90%

JEPI

1D
0.59%
1M
1.56%
YTD
1.89%
6M
1.70%
1Y
8.98%
3Y*
9.19%
5Y*
7.65%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBE vs. JEPI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PBE
Invesco Dynamic Biotechnology & Genome ETF
3.32%24.84%1.10%3.71%-10.83%1.54%19.55%
JEPI
JPMorgan Equity Premium Income ETF
1.89%8.09%12.57%9.83%-3.49%21.52%18.39%

Correlation

The correlation between PBE and JEPI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.54

Correlation (3Y)
Calculated over the trailing 3-year period

0.60

Correlation (5Y)
Calculated over the trailing 5-year period

0.59

Correlation (All Time)
Calculated using the full available price history since May 21, 2020

0.55

The correlation between PBE and JEPI has been stable across timeframes, ranging from 0.54 to 0.60 - a consistent structural relationship.

PBE vs. JEPI - Sectors Allocation Comparison


Sectors
PBE
JEPI

Healthcare

99.9%
12.0%

Financial Services

0.2%
7.4%

Basic Materials

-

1.6%

Communication Services

-

6.2%

Consumer Cyclical

-

10.1%

Consumer Defensive

-

8.1%

Energy

-

2.7%

Industrials

-

9.5%

Real Estate

-

2.9%

Technology

-

14.5%

Utilities

-

4.7%

Healthcare

PBE
99.9%
JEPI
12.0%

Financial Services

PBE
0.2%
JEPI
7.4%

Basic Materials

PBE

-

JEPI
1.6%

Communication Services

PBE

-

JEPI
6.2%

Consumer Cyclical

PBE

-

JEPI
10.1%

Consumer Defensive

PBE

-

JEPI
8.1%

Energy

PBE

-

JEPI
2.7%

Industrials

PBE

-

JEPI
9.5%

Real Estate

PBE

-

JEPI
2.9%

Technology

PBE

-

JEPI
14.5%

Utilities

PBE

-

JEPI
4.7%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PBE vs. JEPI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBE
PBE Risk / Return Rank: 5858
Overall Rank
PBE Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
PBE Sortino Ratio Rank: 6363
Sortino Ratio Rank
PBE Omega Ratio Rank: 5353
Omega Ratio Rank
PBE Calmar Ratio Rank: 6363
Calmar Ratio Rank
PBE Martin Ratio Rank: 5252
Martin Ratio Rank

JEPI
JEPI Risk / Return Rank: 3333
Overall Rank
JEPI Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
JEPI Sortino Ratio Rank: 3434
Sortino Ratio Rank
JEPI Omega Ratio Rank: 3333
Omega Ratio Rank
JEPI Calmar Ratio Rank: 3030
Calmar Ratio Rank
JEPI Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBE vs. JEPI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and JPMorgan Equity Premium Income ETF (JEPI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PBEJEPIDifference
Sharpe ratioReturn per unit of total volatility

+0.68

Sortino ratioReturn per unit of downside risk

+1.00

Omega ratioGain probability vs. loss probability

1.31

1.21

+0.10

Calmar ratioReturn relative to maximum drawdown

2.92

1.35

+1.57

Martin ratioReturn relative to average drawdown

8.21

4.09

+4.12

PBE vs. JEPI - Sharpe Ratio Comparison

The current PBE Sharpe Ratio is 1.81, which is higher than the JEPI Sharpe Ratio of 1.13. The chart below compares the historical Sharpe Ratios of PBE and JEPI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PBE vs. JEPI - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, which is greater than JEPI's maximum drawdown of -13.71%. Use the drawdown chart below to compare losses from any high point for PBE and JEPI.


Loading charts...

Drawdown Indicators


PBEJEPIDifference

Max Drawdown

Largest peak-to-trough decline

-45.69%

-13.71%

-31.98%

Max Drawdown (1Y)

Largest decline over 1 year

-11.73%

-6.68%

-5.05%

Max Drawdown (3Y)

Largest decline over 3 years

-22.43%

-13.26%

-9.17%

Max Drawdown (5Y)

Largest decline over 5 years

-34.71%

-13.71%

-21.00%

Max Drawdown (10Y)

Largest decline over 10 years

-37.84%

Current Drawdown

Current decline from peak

-1.00%

-3.18%

+2.18%

Average Drawdown

Average peak-to-trough decline

-16.21%

-2.13%

-14.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.17%

2.20%

+1.97%

Volatility

PBE vs. JEPI - Volatility Comparison

Invesco Dynamic Biotechnology & Genome ETF (PBE) has a higher volatility of 6.04% compared to JPMorgan Equity Premium Income ETF (JEPI) at 2.12%. This indicates that PBE's price experiences larger fluctuations and is considered to be riskier than JEPI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PBEJEPIDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.04%

2.12%

+3.92%

Volatility (6M)

Calculated over the trailing 6-month period

13.67%

6.23%

+7.44%

Volatility (1Y)

Calculated over the trailing 1-year period

19.01%

8.01%

+11.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.48%

11.08%

+11.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.91%

10.79%

+14.12%

PBE vs. JEPI - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than JEPI's 0.35% expense ratio.


Dividends

PBE vs. JEPI - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 1.02%, less than JEPI's 8.13% yield.


PositionTTM20252024202320222021202020192018201720162015
JEPI
JPMorgan Equity Premium Income ETF
8.13%8.25%7.33%8.40%11.68%6.59%5.79%0.00%0.00%0.00%0.00%0.00%
PBE
Invesco Dynamic Biotechnology & Genome ETF
1.02%1.00%0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%

Frequently Asked Questions


PBE and JEPI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PBE has higher volatility (6.04%) compared to JEPI (2.12%). In terms of maximum drawdown, PBE dropped -45.69% vs JEPI's -13.71%.

On 5-year performance, JEPI leads with 7.65% vs 2.31% for PBE. On fees, JEPI is cheaper at 0.35% per year. On volatility, JEPI has been the lower-risk option at 2.12%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, JEPI has performed better with a 7.65% return vs 2.31%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

JEPI is cheaper with a 0.35% expense ratio, compared with 0.59% for PBE.

JEPI has the higher dividend yield at 8.13%, compared with 1.02% for PBE.

PBE is categorized as Health & Biotech Equities, while JEPI is Dividend. They also come from different issuers: Invesco and JPMorgan. Their fees differ too: 0.59% for PBE and 0.35% for JEPI.

PBE currently has the higher Sharpe Ratio (1.81 vs 1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PBE and JEPI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer